Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

202030 citationsJournal Articlehybrid Open Access

Authors

Christian Veltmann · Medizinische Hochschule Hannover

Stefan Winter · University Hospital Cologne

David Duncker · Medizinische Hochschule Hannover

Carsten Jungbauer · University Hospital Regensburg

Nadine K. Wäßnig

J. Christoph Geller · Otto-von-Guericke University Magdeburg

Julia W. Erath · Goethe University Frankfurt

Abstract

Mortality after WCD prescription was mainly driven by heart failure and non-cardiovascular death. In patients with HFrEF and a potential risk of sudden arrhythmic death, WCD protected observation of LVEF progression and appraisal of competing risks of potential non-arrhythmic death may enable improved selection for beneficial ICD implantation.

Topics & Keywords

Cardiac pacing and defibrillation studies Cardiac Arrhythmias and Treatments Cardiomyopathy and Myosin Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Research in Cardiology

Volume 110, Issue 1, pp. 102-113

DOI: 10.1007/s00392-020-01657-2

Field-Weighted Citation Impact: 2.10